Apr 3 |
YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility
|
Mar 5 |
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries
|
Feb 22 |
YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024
|
Feb 18 |
/C O R R E C T I O N -- YS Biopharma Co., Ltd./
|
Feb 9 |
YS Biopharma announces $40M private placement
|
Feb 9 |
YS Biopharma Announces US$40 Million Private Placement Financing
|
Feb 8 |
Shareholders of YS Biopharma Announce an Extraordinary General Meeting
|
Jan 22 |
YS Biopharma GAAP EPS of -$0.26, revenue of $38.04M
|
Jan 22 |
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
|
Jan 8 |
YS Biopharma Announces Changes to its Board Committees
|